Assessing the Effects of Corn and Avocado Oils on the Cardiometabolic Risk Factor Profile (NCT07514663)
A Randomized, Double-Blind, Controlled Feeding, Crossover Trial to Assess the Effects of Corn and Avocado Oils on the Cardiometabolic Risk Factor Profile in Men and Women
🩺 Plain-English Summary (8th-Grade Level)
The goal of this clinical trial is to assess the effects of corn and avocado oils as part of controlled feeding diets on the cardiometabolic risk factor profile in men and women with mild-to-moderately elevated levels of non-high-density lipoprotein cholesterol (non-HDL-C). Participants will be asked to consume the controlled feeding diet for two separate 21 day conditions, and will consume their regular diet for a 21 day washout period between the two conditions. Additionally, participants will be asked to come into the clinic on 7 different occasions, including one screening visit (visit 1, -7 days), one baseline visit (visit 2, day 0), two visits during each 21-d diet condition (visits 3 \& 6, day 19 and visits 4 \& 7, day 21), and a visit at the conclusion of the washout phase/start of the second diet condition (visit 5, day 0).
Who can join: Review the eligibility criteria below.
Location: Biofortis Clinical Research — Addison, Illinois
Age range: 18 Years to 74 Years
🧪 Interventions in This Study
- corn oil (OTHER)
- Avocado Oil (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Biofortis Clinical Research — Addison, Illinois
📞 Contact the Study Coordinator
Phone: (630) 469-6600
Email: cwolfe@mbclinicalresearch.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Hypercholesterolemia
- Open-label Extension Study of Enlicitide Decanoate (MK-0616/Enlicitide Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-019) CORALreef Extension — Daphne, Alabama
- Impact of Ketogenic Diets on Cardiovascular Health in Adults With Epilepsy — Baltimore, Maryland
- Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia — Clearwater, Florida
- A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia — Anniston, Alabama
- Causes and Natural History of Dyslipidemias — Bethesda, Maryland
Explore by condition: All Hypercholesterolemia clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.